Tomoyuki Fujisawa

7.7k total citations
222 papers, 4.7k citations indexed

About

Tomoyuki Fujisawa is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Tomoyuki Fujisawa has authored 222 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 161 papers in Pulmonary and Respiratory Medicine, 63 papers in Physiology and 47 papers in Epidemiology. Recurrent topics in Tomoyuki Fujisawa's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (115 papers), Sarcoidosis and Beryllium Toxicity Research (34 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (32 papers). Tomoyuki Fujisawa is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (115 papers), Sarcoidosis and Beryllium Toxicity Research (34 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (32 papers). Tomoyuki Fujisawa collaborates with scholars based in Japan, United States and China. Tomoyuki Fujisawa's co-authors include Takafumi Suda, Naoki Inui, Noriyuki Enomoto, Yutaro Nakamura, Hironao Hozumi, Yuzo Suzuki, Dai Hashimoto, Masato Kono, Kazuki Furuhashi and Kingo Chida and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Tomoyuki Fujisawa

206 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoyuki Fujisawa Japan 37 3.1k 1.4k 1.3k 735 619 222 4.7k
Yutaro Nakamura Japan 40 3.3k 1.1× 1.4k 1.0× 1.4k 1.0× 787 1.1× 543 0.9× 206 5.0k
Noriyuki Enomoto Japan 35 3.0k 1.0× 1.3k 1.0× 1.3k 0.9× 799 1.1× 519 0.8× 237 4.4k
Sonoko Nagai Japan 38 4.3k 1.4× 1.4k 1.0× 2.0k 1.5× 787 1.1× 463 0.7× 117 5.8k
Paolo Spagnolo Italy 45 4.7k 1.5× 917 0.7× 2.2k 1.7× 552 0.8× 373 0.6× 179 6.2k
Mary E. Strek United States 40 4.4k 1.4× 1.3k 1.0× 1.9k 1.4× 777 1.1× 295 0.5× 124 5.5k
Robert Vassallo United States 47 3.4k 1.1× 915 0.7× 2.9k 2.2× 1.1k 1.5× 988 1.6× 152 6.7k
Imre Noth United States 41 5.3k 1.7× 937 0.7× 2.0k 1.5× 757 1.0× 246 0.4× 143 6.1k
Antje Prasse Germany 42 4.4k 1.4× 913 0.7× 2.6k 1.9× 507 0.7× 1.1k 1.8× 163 6.7k
Francesco Bonella Germany 41 3.9k 1.2× 576 0.4× 1.3k 1.0× 422 0.6× 253 0.4× 212 4.5k
Dominique Israël‐Biet France 32 2.3k 0.7× 999 0.7× 761 0.6× 257 0.3× 511 0.8× 151 4.3k

Countries citing papers authored by Tomoyuki Fujisawa

Since Specialization
Citations

This map shows the geographic impact of Tomoyuki Fujisawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyuki Fujisawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyuki Fujisawa more than expected).

Fields of papers citing papers by Tomoyuki Fujisawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoyuki Fujisawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyuki Fujisawa. The network helps show where Tomoyuki Fujisawa may publish in the future.

Co-authorship network of co-authors of Tomoyuki Fujisawa

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoyuki Fujisawa. A scholar is included among the top collaborators of Tomoyuki Fujisawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoyuki Fujisawa. Tomoyuki Fujisawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inoue, Yusuke, Masato Karayama, Hideki Yasui, et al.. (2025). Massive immune-related myositis and cytokine release syndrome during dual immunotherapy plus chemotherapy for recurrent lung adenocarcinoma: case report. Respiratory Medicine Case Reports. 58. 102304–102304.
2.
Miyashita, Koichi, Hironao Hozumi, Eiji Nakatani, et al.. (2025). Outcomes of COVID-19 in the Omicron-predominant wave: large-scale real-world data analysis with a comparison to influenza. PubMed. 17(1). 3–3.
3.
Enomoto, Yasunori, Ryo Horiguchi, Shiori Meguro, et al.. (2025). Integrin α8 is a useful cell surface marker of alveolar lipofibroblasts. Respiratory Research. 26(1). 14–14.
4.
Hozumi, Hironao, Shintaro Ichikawa, Yusuke Inoue, et al.. (2024). Association of interstitial lung abnormalities with cytotoxic agent-induced pneumonitis in patients with malignancy. Respiratory Medicine. 237. 107924–107924.
5.
Suzuki, Yuzo, Ryo Horiguchi, Yuya Aono, et al.. (2024). CD109 Attenuates Bleomycin-induced Pulmonary Fibrosis by Inhibiting TGF-β Signaling. The Journal of Immunology. 212(7). 1221–1231. 3 indexed citations
6.
Miyashita, Koichi, Hironao Hozumi, Eiji Nakatani, et al.. (2024). Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study. Respiratory Research. 25(1). 95–95. 3 indexed citations
7.
Watanabe, Hirofumi, Yusuke Inoue, Masato Karayama, et al.. (2024). Characterization of BRAFThr599dup Mutation as a Targetable Driver Mutation Identified in Lung Adenocarcinoma by Comprehensive Genomic Profiling. JCO Precision Oncology. 8(8). e2300538–e2300538.
8.
Suzuki, Yuzo, Masato Kono, Hirotsugu Hasegawa, et al.. (2023). Neutrophil–lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis. BMJ Open Respiratory Research. 10(1). e001763–e001763. 6 indexed citations
9.
Suzuki, Yuzo, Masato Kono, Hirotsugu Hasegawa, et al.. (2023). Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis. Respirology. 28(8). 775–783. 23 indexed citations
10.
Suzuki, Yuzo, Kazutaka Mori, Yuya Aono, et al.. (2022). Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis. Thorax. 77(7). 727–730. 20 indexed citations
11.
Fujisawa, Tomoyuki, Koji Nishimoto, Katsuhiro Yoshimura, et al.. (2021). Prognostic significance of peripheral blood monocyte and neutrophil counts in rheumatoid arthritis-associated interstitial lung disease. Respiratory Medicine. 182. 106420–106420. 16 indexed citations
12.
13.
Karayama, Masato, Naoki Inui, Hideki Yasui, et al.. (2018). Prophylactic aprepitant is better than salvage for carboplatin-based chemotherapy: a propensity score-matched analysis. Medical Oncology. 35(11). 139–139. 4 indexed citations
14.
Fujisawa, Tomoyuki, Kazutaka Mori, Hideki Yasui, et al.. (2018). IL-17A Attenuates IFN-λ Expression by Inducing Suppressor of Cytokine Signaling Expression in Airway Epithelium. The Journal of Immunology. 201(8). 2392–2402. 21 indexed citations
15.
Kusagaya, Hideki, Tomoyuki Fujisawa, Noriyuki Enomoto, et al.. (2015). Co-occurrence of Pneumoperitoneum and Pneumothorax in a Patient with Pleuroparenchymal Fibroelastosis. American Journal of Respiratory and Critical Care Medicine. 191(10). 1200–1201. 6 indexed citations
16.
Suzuki, Yuzo, Takafumi Suda, Kazuki Furuhashi, et al.. (2012). Mouse CD11bhigh Lung Dendritic Cells Have More Potent Capability to Induce IgA than CD103+ Lung Dendritic Cells In Vitro. American Journal of Respiratory Cell and Molecular Biology. 46(6). 773–780. 20 indexed citations
17.
Furuhashi, Kazuki, Takafumi Suda, Hirotsugu Hasegawa, et al.. (2011). Mouse Lung CD103+ and CD11bhigh Dendritic Cells Preferentially Induce Distinct CD4+ T-Cell Responses. American Journal of Respiratory Cell and Molecular Biology. 46(2). 165–172. 91 indexed citations
18.
Fujisawa, Tomoyuki, Mary Chang, Sharlene Velichko, et al.. (2010). NF-κB Mediates IL-1β– and IL-17A–Induced MUC5B Expression in Airway Epithelial Cells. American Journal of Respiratory Cell and Molecular Biology. 45(2). 246–252. 100 indexed citations
19.
Oslund, Karen, Philip Thai, Sharlene Velichko, et al.. (2010). 2,3,7,8-Tetrachlorodibenzo-p-dioxin–Induced MUC5AC Expression. American Journal of Respiratory Cell and Molecular Biology. 45(2). 270–276. 19 indexed citations
20.
Fujisawa, Tomoyuki, Kyotaro Ide, Michael J. Holtzman, et al.. (2008). Involvement of the p38 MAPK pathway in IL‐13‐induced mucous cell metaplasia in mouse tracheal epithelial cells. Respirology. 13(2). 191–202. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yutaro Nakamura Breakdown of academic impact, for papers by Noriyuki Enomoto Breakdown of academic impact, for papers by Sonoko Nagai Breakdown of academic impact, for papers by Paolo Spagnolo Breakdown of academic impact, for papers by Mary E. Strek Breakdown of academic impact, for papers by Robert Vassallo Breakdown of academic impact, for papers by Imre Noth Breakdown of academic impact, for papers by Antje Prasse Breakdown of academic impact, for papers by Francesco Bonella Breakdown of academic impact, for papers by Dominique Israël‐Biet
Rankless by CCL
2026